| BC | Breast Cancer |
| TILs | tumor infiltrating lymphocytes |
| DCs | dendritic cells |
| Tregs | CD4+ regulatory T cells |
| CIC | cancer-immunity cycle |
| TIME | tumor immune microenvironment |
| CYT | immune cytolytic activity |
| TCGA | The Cancer Genome Atlas |
| METABRIC | Molecular Taxonomy of Breast Cancer International Consortium |
| TN | triple negative |
| ER | estrogen receptor |
| PgR | progesterone receptor |
| HR | hormone receptor |
| TMB | tumor mutation burden |
| SNV | single-nucleotide variant |
| IFN | interferon |
| GSEA | Gene Set Enrichment Analyses |
| NES | normalized enrichment score |
| FDR | false discovery rate |
| OS | overall survival |
| HER2 | human epidermal growth factor receptor 2 |
| PFS | progression free survival |
| BCSS | breast cancer specific survival |
| NCI | National Cancer Institute |
| TPM | Transcripts Per Million |
| RFS | recurrence-free survival |